CONSULTING AGREEMENT


 


THIS AGREEMENT
(the “Agreement”) dated December 15, 2010 ("Effective Date") is made by and between Morria
Biopharmaceuticals, Plc., whose address is 53 Davies Street, Mayfaire, London (the “Company”); and AGH Associates
having an address of 190 East 72nd Street Suite 32C, New York, NY 10021 (the “Consultant”).


 


The Company wishes
to retain the Consultant in a consulting capacity and the Consultant desires to perform such consulting services. Accordingly,
the parties agree as follows:


 


1. Services.


 


1.1 The Services under
this contract shall be performed solely by Alan Harris in his personal capacity on behalf of AGH Associates. Alan Harris shall
have the title of Medical Consultant, and agrees to be presented at meetings, on documentation, and on the Company web sites as
the Medical Consultant of Company.


 


1.2 The Consultant
will: 1) review the Company's draft clinical trial report from its Phase II allergic rhinitis study and other documents or information
relating to the Company's allergic rhinitis/respiratory program; 2) revise and draft the full clinical trial report from its Phase
II allergic rhinitis study; 3) review and/or revise and /or prepare the protocol for the allergen chamber study; 4) participate
in discussions and meetings regarding he Company’s allergic rhinitis program; 5) advise the Company on its clinical development
of its allergic rhinitis program or other programs; and 6) advise the Company on regulatory path and strategy (the "Field
of Interest").


 


1.3 Consultant will
provide the Services to be provided in 1.1 subject to reasonable professional availability ("Consulting Time").
Consultation may be sought by the Company over the telephone, in person, at the Company's offices or another reasonable location
or through written correspondence, and will involve reviewing activities, meetings, and developments in the Field of Interest.


 


2.
Cash Compensation. The Consultant will be paid a fee of $350.00 USD per hour, provided that each such hour shall
be authorized by the Company in advance. The Consultant shall give the Company an invoice at
the end of each calendar month, which include the number of hours, be they whole, or portions of an hour, worked and other pertinent
information. Payment shall occur no later than thirty (30) days' following receipt by the Company of an invoice issued by the Consultant
or at the end of the month wherein the Company received such invoice, whichever is later. The Consultant shall provide the Company
with a receipt following the payment being made. A detailed accounting of Consulting Time, including
date, time and service provided, should be forwarded to the Company. Payment will be made at the per diem rate as defined above
for all Consulting Time. Reasonable expenses of the Consultant incurred at the request of the Company (including travel expenses
incurred in connection with Company related business in accordance with the Company's travel policy) will be reimbursed promptly
by the Company, subject to customary verification and prior written approval.


 


/Yuval Cohen/

/Alan Harris/


 



    	 



    	 



    

 


3. Term.


 





 3.1 The term of this Agreement
will begin on the Effective Date of this Agreement and will end on the first anniversary of this Agreement (the "Term").
The Term may be renewed for successive one-year periods provided both parties provide written agreement. This Agreement
may be terminated by either party for any reason at any time by giving thirty (30) days' prior written notice to the other party,
during which the Consultant shall continue, upon the Company’s sole discretion, to provide the Consulting Services. The
Agreement shall terminate immediately upon the Company’s notice on such election, but the Company will pay the Consultant
any outstanding fees invoiced prior to such notice.


 


3.2 On termination
of this Agreement for any reason whatsoever, and before the Company pays the Consultant the final payment, the Consultant undertakes:
(1) to return and have the Consultant return to the Company the Confidential Information and all documents, drawings, magnetic
media, letters, reports and all other documents belonging to the Company and/or related to the Company’s activities and/or
to the Consulting Services; and to return any equipment and/or other property of the Company; (2) to erase, at the Company’s
offices and in the presence of the Company’s representative, all information relating to the Company or its activities which
exists in the Consultant’s computers and/or Consultant’s personal computer(s); (3) to assist and have the Consultant
assist in the transferring of the position, matters and documents under the Consultant’s supervision to whomever the Company
shall determine. If the Company’s equipment shall be returned damaged, the Company shall have the right to set off the costs
of such damages from the payment due to the Consultant


 


4. Certain Other
Contracts.


 


4.1 The Consultant
will not disclose to the Company any information that the Consultant is obligated to keep secret pursuant to an existing confidentiality
agreement with a third party, and nothing in this Agreement will impose any obligation on the Consultant to the contrary.


 


4.2 The consulting
work performed hereunder will not be conducted on time that is required to be devoted to any other third party. The Consultant
shall not use the funding, resources and facilities of any other third party to perform consulting work hereunder and shall not
perform the consulting work hereunder in any manner that would give any third party rights to the product of such work.


 


4.3 The Consultant
has disclosed and, during the Term, will disclose to the Company any conflicts between this Agreement and any other agreements
binding the Consultant.


 


5. Exclusive Services
During the Term. Subject to written waivers that may be provided by the Company upon request, which shall not be unreasonably
withheld, the Consultant agrees that during the Term of this Agreement he will not directly or indirectly (i) provide any services
in the Field of Interest for lipid based products to any other business or commercial entity, (ii) participate in the formation
of any business or commercial entity in the Field of Interest for lipid based products, or (iii) solicit or hire away any employee
or consultant of the Company during the Term and for twelve (12) months thereafter.


 


/Yuval Cohen/

/Alan Harris/


 



    	 



    	 



    








 


6. The term "Confidential Information"
shall mean any and all confidential and/or proprietary knowledge, materials, data or information of the Company and its affiliates.
By way of illustration but not limitation, " Confidential Information" includes (a)  samples, materials, compounds,
methods, procedures and formulations, products, processes, ideas, know-how, trade secrets, drawings, inventions, intellectual property,
improvements, formulas, equations, developmental or experimental work, research or clinical data, discoveries, developments, designs,
techniques, instruments, devices, computer software and hardware (collectively, "Inventions"); and (b) information
regarding research, development, regulatory, results, studies, data, new service offerings or products, marketing and selling,
business plans, business methods, budgets, finances, licensing, collaboration and development arrangements, prices and costs, buying
habits and practices, contact and mailing lists and databases, vendors, customers and clients, and potential business opportunities;
and (c) information regarding the names, addresses, identities, skills and compensation of employees, independent contractors and
consultants of the Company and its affiliates and (d) any other information regarding the Company, its affiliates and their businesses
that the Company and its affiliates treat in a confidential manner and is not readily available to the public and any results,
materials, processes, and information resulting from or derived from the use of or based on or from (a), (b), (c) and/or (d).


 


7. Inventions Discovered
by the Consultant While Performing Services Hereunder.


 


7.1 The Consultant
will promptly and fully disclose to the Company any and all Invention made, conceived, developed, or first reduced to practice
by the Consultant, either alone or jointly with others, while performing services hereunder. The Consultant hereby assigns to the
Company and will assign all of his right, title and interest in and to any such Inventions. The Consultant will execute any documents
necessary to perfect the assignment of such Inventions to the Company and to enable the Company to apply for, obtain, and enforce
patents or copyrights in any and all countries on such Inventions. The Consultant hereby irrevocably designates the Secretary of
the Company as his agent and attorney-in-fact to execute and file any such document and to do all lawful acts necessary to apply
for and obtain patents and copyrights, and to enforce the Company's rights under this paragraph. This Section 6 will survive the
termination of this Agreement.


 


7.2
Any and all knowledge, materials, data or information of the Company and its affiliates and any resulting or derivative
data, information, materials, or know how therefrom, shall be solely owned by the Company and the Company shall have the sole and
exclusive right, title, and interest in and to all such confidential and/or proprietary knowledge, materials, data or information
of the Company and its affiliates. Consultant shall have no rights or interest in any such materials,
data, and information.


 


8. Confidentiality.


 


8.1 The Consultant
agrees that the Confidential Information will be used by the Consultant only in connection with consulting activities hereunder,
and will not be used, transferred, conveyed, disclosed for any other purpose or to any other person or entity.


 


8.2 The Consultant
agrees not to disclose, directly or indirectly, the Confidential Information to any third person or entity, other than representatives
or agents of the Company. The Consultant will treat all such information under the Services and in Section 6 and 7 as confidential
and proprietary property of the Company. Any information which is in the public domain such information shall not be considered
confidential under this agreement.


 


8.3
 The Consultant agrees to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in
any other form that may be required by the Company) of all proprietary and Confidential Information developed by Consultant which
records shall be available to and remain the sole property of the Company at all times. The Consultant
shall continue to be bound by the terms of the confidentiality and non-use provisions contained in this Section 7 for a period
of five years after the termination of this Agreement.


 


/Yuval Cohen/

/Alan Harris/


 



    	 



    	 



    




  


9. Use of Name.
It is understood that the name of the Consultant and Consultant's affiliation with the Institution will appear in disclosure documents
required by securities laws, and in other regulatory and administrative filings in the ordinary course of the Company's business.
The above described uses will be deemed to be non-commercial uses. The name of the Consultant or the Institution will not be used
for any commercial purpose without the Consultant's consent.


 


10. No Conflict:
Valid and Binding. The Consultant represents that neither the execution of this Agreement nor the performance of the Consultant's
obligations under this Agreement will result in a violation or breach of any other agreement by which the Consultant is bound.
The Company represents that this Agreement has been duly authorized and executed and is a valid and legally binding obligation
of the Company, subject to no conflicting agreements.


 


11. Notices.
Any notice provided under this Agreement shall be in writing and shall be deemed to have been effectively given (i) upon receipt
when delivered personally, (ii) one day after sending when sent by private express mail service (such as Federal Express), or (iii)
5 days after sending when sent by regular mail to the following address:


 


In the case of the Company:


 


Mark Cohen


Pearl Cohen Zedek Latzer, LLP


1500 Broadway, 12th Floor


New York, NY 10036


Fax: 646 878 0801


Email: markc@pczlaw.com


  


In the case of the Consultant:


 


AGH Associates


Attention: Alan Harris


_______________________


_______________________


Facsimile: ______________


Email:__________________


 


or to other such address as may have been designated by the
Company or the Consultant by notice to the other given as provided herein.


 


 12. Independent Contractor. Withholding. The Consultant will at all times be an independent
contractor, and as such will not have authority to bind the Company. Consultant will not act as an agent nor shall he be deemed
to be an employee of the Company for the purposes of any employee benefit program, unemployment benefits, or otherwise. The Consultant
recognizes that no amount will be withheld from his compensation for payment of any federal, state, or local taxes and that the
Consultant has sole responsibility to pay such taxes, if any, and file such returns as shall be required by applicable laws and
regulations.


 


/Yuval Cohen/

/Alan Harris/


 



    	 



    	 



    

 


13. Assignment.
Due to the personal nature of the services to be rendered by the Consultant, the Consultant may not assign this Agreement. The
Company may assign all rights and liabilities under this Agreement to a subsidiary or an affiliate or to a successor to all or
a substantial part of its business and assets without the consent of the Consultant. Subject to the foregoing, this Agreement will
inure to the benefit of and be binding upon each of the heirs, assigns and successors of the respective parties.


 


14. Severability.
If any provision of this Agreement shall be declared invalid, illegal or unenforceable, such provision shall be severed and the
remaining provisions shall continue in full force and effect.


 


15. Remedies.
The Consultant acknowledges that the Company would have no adequate remedy at law to enforce. In the event of a violation by the
Consultant of such Sections, the Company shall have the right to obtain injunctive or other similar relief, as well as any other
relevant damages, without the requirement of posting bond or other similar measures.


 


16.
Governing Law; Entire Agreement; Amendment. This Agreement shall be governed by the substantive laws of New York
and under the exclusive jurisdiction of the New York courts.


 


/Yuval Cohen/

/Alan Harris/


 



    	 



    	 



    




  


IN WITNESS WHEREOF, the parties have executed
this Agreement as of the date first written above.


 


	Morria Biopharmaceuticals, Plc.	CONSULTANT:


 


	By:	/s/ Yuval Cohen	 	By:	/s/ Alan Harris


 


	Name: Yuval Cohen	 	Name: Alan Harris
	 	 	 
	Title: President	 	Title: President AGH Associates INC